Last checked at 23 Oct 2017 15:30
 | 23 October 2017 |
Futura Medical plc
("Futura" or "the Company")
PDMR Dealing
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology has been notified that Rachael Hawken, a person discharging managerial responsibilities ("PDMR"), has purchased 19,581 shares of 0.2p each in the Company ("Ordinary Shares") into her Self-Invested Personal Pension ("SIPP").
Further details are contained within the notification below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
Â
For further information please contact:
Futura Medical plc |
James Barder, Chief Executive + 44 (0) 1483 685 670 james.barder@futuramedical.com www.futuramedical.com |
N+1 Singer (Nominated Adviser and Broker)Aubrey Powell / Liz Yong +44 (0) 20 7496 3000 |
 |
For media enquiries please contact: |
Buchanan |
Mark Court / Sophie Wills /Stephanie Watson + 44 (0) 20 7466 5000 |
Â
Â
Notes to editors:
Â
About Futura Medical plc
Â
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Â
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Â
www.futuramedical.com
Â
Â
Â
Â
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Â
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | |||||
a)  | Name  | Rachael Hawken | ||||
2  | Reason for the notification  | |||||
a)  | Position/status  | PDMR | ||||
b)  | Initial notification /Amendment  | Initial notification | ||||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | |||||
a)  | Name  | Futura Medical plc | ||||
b) Â | LEI Â | 21380053QLT46UNV2303 | ||||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  | |||||
a)  | Description of the financial instrument, type of instrument  Identification code  |  Ordinary shares of 0.2p each  GB0033278473 | ||||
b)  | Nature of the transaction  | Transfer of shares to SIPP through purchase by SIPP | ||||
c)  | Prices and volumes   | Â
| ||||
d)  | Aggregated information  - Aggregated volume  - Price  |   19,581 ordinary shares of 0.2p each  24.13447 pence  | ||||
e)  | Date of the transaction  | (i) 18 October 2017 (ii) 23 October 2017  | ||||
f)  | Place of the transaction  | (i) XLON (ii) XLON  | ||||
Â
Â